Home/Filings/4/0001382963-20-000030
4//SEC Filing

Ritter Andrew J 4

Accession 0001382963-20-000030

CIK 0001460702other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:13 PM ET

Size

5.5 KB

Accession

0001382963-20-000030

Insider Transaction Report

Form 4
Period: 2020-03-04
Ritter Andrew J
DirectorPresident
Transactions
  • Sale

    Common Stock

    2020-03-04$0.38/sh18,750$7,04381,727 total(indirect: By LLC)
Holdings
  • Common Stock

    625
Footnotes (1)
  • [F1]As a managing partner of Stonehenge Partners LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.

Issuer

RITTER PHARMACEUTICALS INC

CIK 0001460702

Entity typeother

Related Parties

1
  • filerCIK 0001631671

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:13 PM ET
Size
5.5 KB